Exploring Gender Differences in the Placebo Response to Major Depressive Disorder (MDD) Using Neuroimaging Techniques

被引:0
|
作者
Jahan, Aava [1 ]
Dillon, Daniel [2 ]
Petibon, Yoann [3 ,4 ]
Meyer, Ashley [1 ]
Normandin, Marc [3 ,4 ]
Belleau, Emily [2 ]
Alpert, Nathaniel [3 ,4 ]
El Fakhri, Georges [3 ,4 ]
Hooker, Jacob [3 ,4 ]
Crowley, David [5 ]
Cusin, Cristina [3 ,4 ]
Pizzagalli, Diego [2 ]
Fava, Maurizio [3 ,4 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, McLean Hosp, Boston, MA USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Harvard Med Sch, Boston, MA 02115 USA
[5] McLean Hosp, 115 Mill St, Belmont, MA 02178 USA
关键词
Depression; Functional Neuroimaging; Dopamine;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:S171 / S172
页数:2
相关论文
共 50 条
  • [31] Gender differences in major depressive disorder in a Hungarian community survey
    Szádóczky, E
    Rihmer, Z
    Papp, ZS
    Vitrai, J
    Füredi, J
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2002, 6 (01) : 31 - 37
  • [32] Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder
    Kang, Seung-Gul
    Cho, Seo-Eun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
  • [33] Implications of a Biosignature Study of the Placebo Response in Major Depressive Disorder
    Fava, Maurizio
    JAMA Psychiatry, 2015, 72 (11) : 1073 - 1074
  • [34] The Nature of Placebo Response in Clinical Studies of Major Depressive Disorder
    Papakostas, George I.
    Ostergaard, Soren D.
    Iovieno, Nadia
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (04) : 456 - 466
  • [35] Computer Aided Detection of Major Depressive Disorder (MDD) Using Electroencephalogram Signals
    Khadidos, Adil O.
    Alyoubi, Khaled H.
    Mahato, Shalini
    Khadidos, Alaa O.
    Mohanty, Sachi Nandan
    IEEE ACCESS, 2023, 11 : 41133 - 41141
  • [36] Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects
    Alvarez-Mon, Miguel A.
    Ortega, Miguel A.
    Garcia-Montero, Cielo
    Fraile-Martinez, Oscar
    Monserrat, Jorge
    Lahera, Guillermo
    Mora, Fernando
    Rodriguez-Quiroga, Alberto
    Fernandez-Rojo, Sonia
    Quintero, Javier
    Alvarez-Mon, Melchor
    PHARMACEUTICALS, 2021, 14 (08)
  • [37] GENDER DIFFERENCE IN ANTIDEPRESSANT-RELATED SEXUAL DYSFUNCTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
    Isaac, J.
    Lee, T.
    Chen, K. Chin
    Yeh, T. Lieh
    Lee, I. Hui
    Chen, P. See
    Lin, S. -H.
    Yang, Y. Kuang
    EUROPEAN PSYCHIATRY, 2012, 27
  • [38] LYMPHOCYTE GLUCOCORTICOID RECEPTOR - PREDICTOR OF SERTRALINE RESPONSE IN ADOLESCENT MAJOR DEPRESSIVE DISORDER (MDD)
    SALEE, FR
    NESBITT, L
    DOUGHERTY, D
    HILAL, R
    NANDAGOPAL, VS
    SETHURAMAN, G
    PSYCHOPHARMACOLOGY BULLETIN, 1995, 31 (02) : 339 - 345
  • [39] The safety and tolerability of duloxetine vs. placebo in the treatment of elderly patients with major depressive disorder (MDD)
    Raskin, J
    Wiltse, C
    Dinkel, J
    Xu, J
    Katona, C
    Gandhi, P
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A47 - A47
  • [40] Astrocytic Alterations in Postmortem Hippocampus in Major Depressive Disorder (MDD)
    Stockmeier, Craig A.
    Cobb, Justin A.
    O'Neill, Katie
    Milner, Jessica N.
    Simpson, Joyce
    Lawrence, Thomas J.
    Mahajan, Gouri
    May, Warren
    Rajkowska, Grazyna
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 56S - 56S